Evidence map›Paper›PMID 27207911›Full record

ArticleThe international journal of neuropsychopharmacology2016

Antidepressant-Like Effects of GM1 Ganglioside Involving the BDNF Signaling Cascade in Mice.

Bo Jiang, Lu Song, Cheng-Niu Wang, Wei Zhang, Chao Huang, Li-Juan Tong

Abstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Sphingolipids in Emotional Well-Being.Journal of neurochemistry · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Ganglioside GM1 and the Central Nervous System.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Article
  8. Changes in ganglioside GM1 expression in glaucomic retina.Journal of neuroscience research · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bo JiangDepartment of Pharmacology, Pharmacy College, Nantong University, Nantong, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Provincial key laboratory of Inflammation and Molecular Drug Target, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Basic Medical Research Centre, Medical College, Nantong University, Nantong, Jiangsu, China (Mr Wang). jiangbo78099@ntu.edu.cn.
Lu SongDepartment of Pharmacology, Pharmacy College, Nantong University, Nantong, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Provincial key laboratory of Inflammation and Molecular Drug Target, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Basic Medical Research Centre, Medical College, Nantong University, Nantong, Jiangsu, China (Mr Wang).
Cheng-Niu WangDepartment of Pharmacology, Pharmacy College, Nantong University, Nantong, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Provincial key laboratory of Inflammation and Molecular Drug Target, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Basic Medical Research Centre, Medical College, Nantong University, Nantong, Jiangsu, China (Mr Wang).
Wei ZhangDepartment of Pharmacology, Pharmacy College, Nantong University, Nantong, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Provincial key laboratory of Inflammation and Molecular Drug Target, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Basic Medical Research Centre, Medical College, Nantong University, Nantong, Jiangsu, China (Mr Wang).
Chao HuangDepartment of Pharmacology, Pharmacy College, Nantong University, Nantong, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Provincial key laboratory of Inflammation and Molecular Drug Target, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Basic Medical Research Centre, Medical College, Nantong University, Nantong, Jiangsu, China (Mr Wang).
Li-Juan TongDepartment of Pharmacology, Pharmacy College, Nantong University, Nantong, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Provincial key laboratory of Inflammation and Molecular Drug Target, Jiangsu, China (Dr Jiang, Mrs Song, Dr Zhang, Dr Huang, and Mrs Tong); Basic Medical Research Centre, Medical College, Nantong University, Nantong, Jiangsu, China (Mr Wang).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDepression is a serious psychiatric disorder that easily causes physical impairments and a high suicide rate. Monosialotetrahexosylganglioside is a crucial ganglioside for the central nervous system and has been reported to affect the function of the brain derived neurotrophic factor system. This study is aimed to evaluate whether monosialotetrahexosylganglioside has antidepressant-like effects.

methodsAntidepressant-like effects of monosialotetrahexosylganglioside were assessed in the chronic social defeat stress model of depression, and various behavioral tests were performed. Changes in the brain derived neurotrophic factor signaling pathway after chronic social defeat stress and monosialotetrahexosylganglioside treatment were also investigated. A tryptophan hydroxylase inhibitor and brain derived neurotrophic factor signaling inhibitors were used to determine the antidepressant mechanisms of monosialotetrahexosylganglioside.

resultsMonosialotetrahexosylganglioside administration significantly reversed the chronic social defeat stress-induced reduction of sucrose preference and social interaction in mice and also prevented the increased immobility time in the forced swim test and tail suspension test. In addition, monosialotetrahexosylganglioside completely ameliorated the stress-induced dysfunction of brain derived neurotrophic factor signaling cascade in the hippocampus and medial prefrontal cortex, 2 regions closely involved in the pathophysiology of depression. Furthermore, the usage of brain derived neurotrophic factor signaling cascade inhibitors, K252a and anti-brain derived neurotrophic factor antibody, each abolished the antidepressant-like effects of monosialotetrahexosylganglioside, while the usage of a serotonin system inhibitor did not.

conclusionsTaken together, our findings suggest that monosialotetrahexosylganglioside indeed has antidepressant-like effects, and these effects were mediated through the activation of brain derived neurotrophic factor signaling cascade.

Indexed as

chronic social defeat stressdepressionhippocampusmedial prefrontal cortex

Identifiers

PMID27207911
PMCPMC5043648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.